Fresenius SE & Co. KGaA Inh.-Akt.(Spons.ADRs) 1/4/o.N.
- BID
10.9
- ASK
11.2
- 459 Units446 Units
- 07/21, 19:35:07 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
5.00%
Market Cap
23.66 Bil.
P/E Ratio
22.71
Dividend Yield
1.41 %
Earnings per Share
0.56 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 10.9 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 07:35:07 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 10.9 | 10.4 |
| PREV. DAY'S PRICE | 10.5 | (07/20) |
| CHANGE DAY BEFORE | +0.40 | 3.81 % |
| 52 WEEK HIGH / LOW | 17.7 (11/03) | 8.45 (06/02) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.26 | 0.21 | 0.56 | 0.90 | 0.99 |
DIVIDENDS PER SHARE | 0.00 | 0.17 | 0.18 | 0.29 | 0.31 |
DIVIDEND YIELD IN % | 0.00 % | 2.17 % | 1.41 % | - | - |
DIVIDEND GROWTH IN % | -100.00 % | - | 3.34 % | - | - |
PRICE - EARNINGS RATIO | - | 38.40 | 22.71 | 11.57 | 10.55 |
PRICE - BOOK RATIO | 0.83 | 0.97 | 1.44 | - | - |
PRICE - SALES RATIO | 0.72 | 0.83 | 1.26 | - | - |
PRICE - CASH FLOW RATIO | 3.54 | 7.07 | 10.65 | - | - |
Master Data
| WKN | A1XCZQ |
| ISIN | US35804M1053 |
| SYMBOL | FREA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | FRESENIUS SE+CO. ADR 1/4 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 2.25 Bil. |
| MARKET CAPITALISATION | 23.66 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 3.96 % | 7.14 % | -2.78 % | -8.70 % | 5.00 % | 61.54 % | -3.67 % | -10.26 % |
| HIGH | 10.70 | 11.00 | 11.00 | 13.10 | 17.70 | 17.70 | 17.70 | 13.10 |
| LOW | 9.70 | 9.25 | 8.45 | 8.45 | 8.45 | 5.90 | 4.88 | 8.45 |
Dividende
pro Aktie
Company profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 15 days)
08/05/26Q2 2026 Earnings Release
(in 15 days)
08/05/26Q2 2026 Earnings Call
(in 106 days)
11/04/26Q3 2026 Earnings Call
(in 106 days)
11/04/26Q3 2026 Earnings Release
(in 217 days)
02/23/27Q4 2026 Earnings Release